Venezuelan Equine Encephalitis Virus, Southern Mexico
José G. Estrada-Franco*, Roberto Navarro-Lopez†, Jerome E. Freier‡, Dionicio Cordova§, Tamara Clements¶, Abelardo Moncayo*, Wenli Kang*, Carlos Gomez-Hernandez#, Gabriela Rodriguez-Dominguez#, George V. Ludwig¶, and Nikos Vasilakis*
Author affiliations: *University of Texas Medical Branch, Galveston, Texas, USA; †Comision Mexico-Estados Unidos para la Prevencion de la Fiebre Aftosa y Otras Enfermedades Exoticas de los Animales, Mexico, Mexico City, Mexico; ‡U.S. Department of Agriculture, Fort Collins, Colorado, USA; §Instituto Nacional de Investigaciones Forestales Agricolas y Pecuarias (INIFAP) Mexico City, Mexico; ¶U.S. Army Medical Research Institute of Infectious Diseases, Ft. Detrick, Maryland, USA; #Instituto de Salud de la Secretaria de Salud de Chiapas, Tuxtla Gutierrez, Chiapas, Mexico
Main Article
Table 4
Titers of IgM, IgG and PRNT in humans positive for VEEV IgM during the sampling period, October–December, 2000a
Community |
Sex |
Age |
IgM titer (ELISA) |
IgG titer (ELISA)b |
PRNT titer |
Roberto Barrios |
Female |
55 |
100 |
400 |
40 |
10 de Abril |
Female |
17 |
1,600 |
<100 |
80 |
10 de Abril |
Male |
14 |
400 |
100 |
20 |
Isla Morelos |
Female |
25 |
400 |
400 |
80 |
Buena Vista |
Female |
43 |
6,400 |
100 |
20 |
Buena Vista |
Male |
37 |
400 |
100 |
40 |
Buena Vista |
Male |
29 |
100 |
400 |
160 |
Buena Vista |
Female |
66 |
100 |
400 |
160 |
Main Article
Page created: April 14, 2011
Page updated: April 14, 2011
Page reviewed: April 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.